Vijayendra Dasari
300 Herston Road
Brisbane, QLD 4006, Australia
Brisbane, QLD 4006, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Lymph node targeted multi-epitope subunit vaccine promotes effective immunity to EBV in HLA-expressing mice.
Journal: Nature communications
Published: June 16, 2022
A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.
Journal: PLoS pathogens
Published: March 01, 2022
Prophylactic and therapeutic strategies for Epstein-Barr virus-associated diseases: emerging strategies for clinical development.
Journal: Expert review of vaccines
Published: April 17, 2019
Designing an effective vaccine to prevent Epstein-Barr virus-associated diseases: challenges and opportunities.
Journal: Expert review of vaccines
Published: March 10, 2017
Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients.
Journal: Molecular therapy. Methods & clinical development
Published: June 08, 2016
Autophagy and proteasome interconnect to coordinate cross-presentation through MHC class I pathway in B cells.
Journal: Immunology and cell biology
Published: May 02, 2016
Impaired Epstein-Barr Virus-Specific Neutralizing Antibody Response during Acute Infectious Mononucleosis Is Coincident with Global B-Cell Dysfunction.
Journal: Journal of virology
Published: May 17, 2015
Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation.
Journal: The Journal of infectious diseases
Published: April 18, 2015
Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunity.
Journal: Human vaccines & immunotherapeutics
Published: January 28, 2014
Last Updated: 09/26/2026